Kim N Chi Selected Research

OC 144-093

8/2005

A phase I pharmacokinetic study of the P-glycoprotein inhibitor, ONT-093, in combination with paclitaxel in patients with advanced cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kim N Chi Research Topics

Disease

150	Prostatic Neoplasms (Prostate Cancer) 10/2022 - 09/2003
64	Neoplasms (Cancer) 01/2022 - 09/2003
25	Neoplasm Metastasis (Metastasis) 02/2022 - 02/2009
18	Disease Progression 10/2022 - 01/2015
16	Pain (Aches) 01/2022 - 10/2004
14	Fatigue 10/2022 - 05/2005
6	Hypertension (High Blood Pressure) 03/2022 - 05/2011
5	Carcinoma (Carcinomatosis) 01/2020 - 08/2014
5	Renal Cell Carcinoma (Grawitz Tumor) 01/2020 - 02/2009
4	Exanthema (Rash) 03/2022 - 01/2019
4	Urinary Bladder Neoplasms (Bladder Cancer) 01/2020 - 04/2010
4	Neutropenia 01/2020 - 08/2005
4	Febrile Neutropenia 01/2020 - 08/2005
4	Circulating Neoplastic Cells 12/2018 - 05/2015
3	Nausea 01/2022 - 05/2005
3	Transitional Cell Carcinoma 02/2006 - 10/2002
2	Diarrhea 01/2022 - 09/2012
2	Sepsis (Septicemia) 01/2022 - 11/2017
2	Pneumonia (Pneumonitis) 10/2021 - 01/2019
2	Seizures (Absence Seizure) 11/2019 - 09/2012
2	Adenocarcinoma 10/2018 - 08/2012
2	Lymphatic Metastasis 07/2017 - 09/2010
2	Hypokalemia 01/2017 - 05/2011
2	Fever (Fevers) 09/2010 - 02/2008
2	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 02/2010 - 12/2005
1	Abdominal Pain (Pain, Abdominal) 01/2022
1	Vomiting 01/2022
1	Myocardial Infarction 10/2021
1	Respiratory Tract Infections (Respiratory Tract Infection) 10/2021

Drug/Important Bio-Agent (IBA)

38	Docetaxel (Taxotere)FDA Link 01/2022 - 10/2004
33	AndrogensIBA 03/2022 - 02/2005
25	Prednisone (Sone)FDA LinkGeneric 02/2022 - 10/2004
25	Abiraterone AcetateIBA 02/2022 - 05/2011
24	enzalutamideIBA 10/2022 - 09/2012
22	abirateroneIBA 01/2022 - 05/2011
21	Androgen Receptors (Androgen Receptor)IBA 01/2022 - 06/2004
16	Hormones (Hormone)IBA 10/2022 - 06/2004
15	Biomarkers (Surrogate Marker)IBA 01/2021 - 08/2012
12	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 12/2016
11	Cell-Free Nucleic AcidsIBA 12/2020 - 05/2015
10	apalutamideIBA 03/2022 - 01/2019
10	Circulating Tumor DNAIBA 01/2021 - 11/2017
10	ClusterinIBA 01/2016 - 06/2004
9	OGX-011IBA 11/2017 - 09/2005
8	Prostate-Specific Antigen (Semenogelase)IBA 01/2022 - 10/2004
6	Pharmaceutical PreparationsIBA 01/2022 - 05/2005
6	PlatinumIBA 11/2020 - 01/2016
5	Antisense OligonucleotidesIBA 08/2013 - 06/2004
4	taxaneIBA 01/2022 - 01/2021
4	Opioid Analgesics (Opioids)IBA 01/2022 - 01/2017
4	Testosterone (Sustanon)FDA Link 10/2021 - 01/2016
4	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2020 - 08/2014
4	PlacebosIBA 01/2020 - 01/2018
4	Alkaline PhosphataseIBA 10/2019 - 01/2016
4	bicalutamide (Casodex)FDA LinkGeneric 05/2015 - 08/2012
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2013
3	AntigensIBA 01/2022 - 12/2020
3	olaparibIBA 07/2021 - 01/2020
3	Paclitaxel (Taxol)FDA LinkGeneric 11/2020 - 07/2005
3	RamucirumabIBA 01/2020 - 01/2016
3	Radium-223IBA 10/2019 - 09/2017
3	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2019 - 10/2004
3	cabazitaxel FDA Link 10/2018 - 06/2015
3	Gonadotropin-Releasing Hormone (GnRH)FDA Link 02/2018 - 05/2015
3	Biological ProductsIBA 04/2016 - 09/2003
3	Cisplatin (Platino)FDA LinkGeneric 04/2016 - 10/2002
3	Calcitriol (Calcijex)FDA LinkGeneric 01/2008 - 11/2006
2	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2022 - 01/2016
2	niraparibIBA 01/2022 - 01/2021
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022 - 01/2020
2	antiarrhythmic peptide (AAP)IBA 01/2021 - 01/2020
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 10/2020 - 01/2020
2	RNA (Ribonucleic Acid)IBA 01/2020 - 01/2017
2	TabletsIBA 11/2019 - 01/2018
2	Hemoglobins (Hemoglobin)IBA 10/2019 - 12/2009
2	cabozantinibIBA 01/2019 - 01/2016
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 02/2018 - 07/2017
2	Messenger RNA (mRNA)IBA 01/2017 - 12/2008
2	Sunitinib (Sutent)FDA Link 12/2016 - 02/2009
2	MicroRNAs (MicroRNA)IBA 04/2013 - 08/2012
2	Phosphotransferases (Kinase)IBA 08/2012 - 06/2004
2	Gemcitabine FDA Link 04/2010 - 02/2006
2	Carboplatin (JM8)FDA LinkGeneric 04/2010 - 10/2002
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2010 - 12/2009
2	VA 061 (VA061)IBA 06/2008 - 01/2008
1	COVID-19 VaccinesIBA 01/2022
1	LigandsIBA 01/2022
1	EPI-506IBA 01/2022
1	Metformin (Glucophage)FDA LinkGeneric 01/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022
1	Amylases FDA Link 01/2022
1	Prednisolone (Predate)FDA LinkGeneric 10/2021
1	ipatasertibIBA 10/2021

Therapy/Procedure

114	Castration 03/2022 - 09/2008
59	Therapeutics 03/2022 - 06/2004
36	Drug Therapy (Chemotherapy) 01/2022 - 02/2005
5	Radiotherapy 01/2022 - 09/2003
4	Immunotherapy 10/2021 - 01/2015
4	Prostatectomy (Retropubic Prostatectomy) 05/2017 - 09/2005
3	Neoadjuvant Therapy 05/2017 - 12/2007